Losartan Potassium Tablet, Film Coated
Product Images NDC 50090-4645

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-4645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904645)

Losartan Potassium 25 mg film-coated tablets label from A-S Medication Solutions. The label indicates a package of 30 oral tablets with storage instructions and a QR code for dosage information. The product NDC is 50090-4645.*

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

A line graph showing the percentage of patients with the primary endpoint over a 60-month study period, comparing Losartan potassium and Atenolol. Losartan potassium is represented by a solid line, and Atenolol by a dotted line, illustrating an adjusted risk reduction of 13% (p=0.021).*

FDA Label Image

Losartanfigure2 (Losartanfigure2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months between two treatments: Atenolol (dotted line) and Losartan Potassium (solid line). The graph shows a divergence favoring Losartan Potassium with an adjusted risk reduction of 25%, p=0.001.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

A figure showing primary endpoint events within demographic subgroups comparing Losartan Potassium and Atenolol event rates. It includes hazard ratios with 95% confidence intervals for primary composite events and stroke (fatal/non-fatal) outcomes across age, gender, race, isolated systolic hypertension, diabetes, and history of cardiovascular disease groups. The chart uses symbols proportional to sample size to indicate relative event rates and favorability between Losartan Potassium and Atenolol.*

FDA Label Image

Losartanfigure4 (Losartanfigure4)

A line graph comparing the percentage of patients with event over time (in months) between Losartan potassium and placebo groups. The y-axis represents the percentage of patients with events, and the x-axis shows months from 0 to 48. The graph indicates risk reduction and a p-value for statistical significance.*

FDA Label Image

Losartanstructure (Losartanstructure)

Chemical structure of Losartan Potassium, illustrating its molecular framework with key functional groups and potassium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.